Literature DB >> 12883467

Complications of salvage esophagectomy.

John D Urschel1, Frank W Sellke.   

Abstract

Definitive chemoradiation (without surgery) is an accepted treatment for esophageal cancer. Persistent or recurrent local disease is not infrequent after chemoradiation, and this is its greatest drawback. Selected patients with isolated local failures of definitive chemoradiation can be salvaged by esophagectomy. However, salvage esophagectomy is a high-risk operation; operative mortality is higher than for standard esophagectomy. In contrast to planned esophagectomy after induction (neoadjuvant) therapy, salvage esophagectomy is often carried out months after completion of definitive chemoradiation. Previous thoracic radiotherapy contributes to the genesis of postoperative complications. Respiratory failure (ARDS, pneumonia) and septic complications of esophageal reconstruction (anastomotic leaks) are major causes of postoperative death. Gastric conduit necrosis, airway necrosis, and tracheogastric fistulae are infrequent but highly lethal complications. We propose modifications of surgical practice that may reduce complications. These include strict guidelines for patient selection, conservative mediastinal dissection, prevention of intraoperative lung injury (barotrauma and oxygen related toxicity), near total esophagectomy with cervical esophagogastric anastomosis, anterior mediastinal reconstruction, judicious use of staged reconstruction, perioperative enteral nutritional support, and aggressive detection and treatment of postoperative complications. By conceptually breaking the operation into component parts, such as resection and reconstruction, and then modifying each component to minimize complications, we believe that the operative mortality of salvage esophagectomy can

Entities:  

Mesh:

Year:  2003        PMID: 12883467

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  6 in total

Review 1.  Current status of and perspectives regarding neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.

Authors:  Hiroshi Saeki; Yuichiro Nakashima; Yoko Zaitsu; Yasuo Tsuda; Yuta Kasagi; Koji Ando; Yu Imamura; Kippei Ohgaki; Shuhei Ito; Yasue Kimura; Akinori Egashira; Eiji Oki; Masaru Morita; Yoshihiko Maehara
Journal:  Surg Today       Date:  2015-03-05       Impact factor: 2.549

Review 2.  Hand-Sewn Versus Stapled Esophagogastric Anastomosis in the Neck: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Authors:  Quan Wang; Xi-Ran He; Chun-Hu Shi; Jin-Hui Tian; Lin Jiang; Sheng-Liang He; Ke-Hu Yang
Journal:  Indian J Surg       Date:  2013-10-09       Impact factor: 0.656

3.  Release of band cells from the bone marrow is impaired by preoperative chemoradiation in patients with esophageal carcinoma: increased risk of postoperative pneumonia.

Authors:  Tatsushi Suwa; Yuko Kitagawa; Takahiro Sasaki; Tomoo Shatari; Masayoshi Sakuma; Masaki Kitajima
Journal:  Langenbecks Arch Surg       Date:  2006-08-19       Impact factor: 3.445

Review 4.  Salvage esophagectomy.

Authors:  Wayne L Hofstetter
Journal:  J Thorac Dis       Date:  2014-05       Impact factor: 2.895

5.  Tracheobronchial lesions following esophagectomy: erosions, ulcers, and fistulae, and the predictive value of lymph node-related factors.

Authors:  Kiyotomi Maruyama; Satoru Motoyama; Yusuke Sato; Kaori Hayashi; Shuetu Usami; Yoshihiro Minamiya; Jun-ichi Ogawa
Journal:  World J Surg       Date:  2009-04       Impact factor: 3.352

6.  Clinical and pathologic evaluation of the effectiveness of neoadjuvant chemoradiation therapy in advanced esophageal cancer patients.

Authors:  Yasunori Akutsu; Hisahiro Matsubara; Kiyohiko Shuto; Masaya Uesato; Mikito Mori; Isamu Hoshino; Toru Shiratori; Yukimasa Miyazawa; Hisao Ito; Takashi Uno
Journal:  World J Surg       Date:  2009-05       Impact factor: 3.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.